Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 21
More JCP Articles
Clinical and Practical Psychopharmacology
ChEIs for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Significant Benefits?
July 31, 2023
Chittaranjan Andrade, MD, takes a closer look at a recent meta-analysis indicating that donepezil, rivastigmine, and galantamine lessened both delusions and hallucinations in Alzheimer disease and Parkinson disease.
Original Research
Race, Ethnicity, and ED Disposition for Mental Health Visits
July 26, 2023
Black patients, especially Black male patients, are overrepresented in inpatient psychiatry. This study examined biases in admission rates among Black patients and, specifically, Black male patients with or without…
Letter to the Editor
Safe Delivery of TMS to Patients With Implanted Devices
July 12, 2023
Tendler et al argue that, in considering transcranial magnetic stimulation (TMS) treatment, providers should refer to recent guidelines and literature reports instead of universally excluding patients based on outdated,…
Letter to the Editor
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
July 3, 2023
Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
